Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Annals of Hematology|July 17, 2026
Acalabrutinib in patients with mantle cell lymphoma subjected to allogeneic hematopoietic cell transplantation. a phase 2 study by the Polish Lymphoma Research Group (PLRG12 trial)Sebastian Giebel, Anna Czyż, Iwona Hus, et al.
Journal of Clinical Medicine|October 16, 2024
Pre-Transplant Dual-Energy X-ray Absorptiometry (DXA)-Derived Body Composition Measures as Predictors of Treatment Outcomes and Early Post-Transplant Complications in Patients with Multiple Myeloma (MM) Treated with Autologous Hematopoietic Stem Cell Transplantation (AutoHSCT)Paula Jabłonowska-Babij, Diana Jędrzejuk, Maciej Majcherek, et al.
International Journal of Molecular Sciences|August 14, 2025
Integrating Molecular Alterations with Immunophenotype and Clinical Characteristics in Myelodysplastic Syndromes: A Single-Center StudyMaciej Majcherek, Krzysztof Przeorski, Aleksandra Mroczkowska-Bękarciak, et al.
Archivum Immunologiae Et Therapiae Experimentalis|June 7, 2024
MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCTJagoda Siemaszko, Marta Dratwa, Agnieszka Szeremet, et al.
Clinical Immunology (Orlando, Fla.)|October 4, 2025
ILT-2 and ILT-4 expression and donor genotype as factors associated with HSCT outcomeJagoda Siemaszko, Piotr Łacina, Donata Szymczak, et al.
Frontiers in Immunology|October 30, 2023
Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cellsJagoda Siemaszko, Piotr Łacina, Donata Szymczak, et al.
Human Immunology|September 27, 2024
Soluble MICA concentrations and genetic variability of MICA and its NKG2D receptor as factors affecting Graft-versus-Host Disease development after allogeneic haematopoietic stem cell transplantationJagoda Siemaszko, Piotr Łacina, Donata Szymczak, et al.
Human Immunology|October 9, 2025
miR-302d-3p expression and genotype are associated with CMV replication after allogeneic haematopoietic stem cell transplantationPiotr Łacina, Rachel E Crossland, Jagoda Siemaszko, et al.
Archivum Immunologiae Et Therapiae Experimentalis|June 25, 2026
NCR1 and NCR3 Expression and Genetic Polymorphism are Associated with CMV Infection after Allogeneic Haematopoietic Stem Cell TransplantationSylwia Biały, Piotr Łacina, Jagoda Siemaszko, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2019
Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) ExperienceMarta Sobas, Anna Czyż, Pau Montesinos, et al.
Pageof 3